Skip to main content

Forschung

Overview

Blood vessels and the brain are in constant communication. When this communication breaks down, disease follows. Our lab studies the neurovascular unit, the close functional relationship between blood vessels, immune cells, and neurons, to understand how it is disrupted in Alzheimer's disease and stroke, and what happens when the two occur together.

Jasmin Hefendehl

Alzheimer's Disease

Alzheimer's disease is a progressive brain disorder characterized by memory loss, cognitive decline, and the accumulation of two hallmark proteins: amyloid and tau. Our lab pursues three interconnected lines of research into how amyloid accumulates, moves, and can be intercepted.

The first focuses on cerebral amyloid angiopathy (CAA), a vascular form of the pathology in which amyloid accumulates around blood vessels rather than in the surrounding brain tissue, impairing their function. Using intravital imaging, we traced this process to intercellular signaling that drives overexpression of an enzyme called soluble epoxide hydrolase. Blocking this enzyme reduced vascular amyloid and improved vessel function (deMeglio et al., Brain, 2026), identifying a potential new therapeutic target for a form of Alzheimer's disease that has proven difficult to treat.

The second examines how amyloid that accumulates in the brain parenchyma is cleared, specifically how it is transported across the blood-brain barrier and out of the brain into the bloodstream. We study the cellular and molecular steps of this clearance route and ask how the process might be enhanced, since a more efficient efflux pathway could reduce the amyloid burden before it drives further vascular and neuronal damage.

The third addresses the earliest phase of disease, before clinical symptoms appear. We track how amyloid begins to accumulate during this pre-symptomatic period and how it relates to the earliest signs of cellular dysfunction, with the aim of identifying this stage as a window for intervention. Because Alzheimer's pathology can precede symptoms by years, understanding what goes wrong at this early point is central to developing treatments that act before significant damage has occurred.

Stroke

A stroke occurs when blood supply to the brain is interrupted, causing acute injury with consequences that can unfold over months or years. Our stroke research follows two lines of investigation.

The first aims to identify biomarkers that predict stroke recurrence. A substantial proportion of stroke survivors experience a second event, often within the first years after the initial injury, and current tools for identifying who is at highest risk remain limited. By characterizing molecular and cellular changes that follow stroke, including microvascular abnormalities such as cerebral microbleeds, we work toward markers that could flag elevated risk before a second stroke occurs, creating a window for preventive intervention.

The second examines silent strokes: small, clinically undetected events that nonetheless alter brain function over time. Unlike major strokes, these episodes produce no obvious symptoms and are often only visible through imaging, yet their cumulative effect on cognition can be substantial. Rather than focusing on biomarkers, this arm of our research uses longitudinal imaging to follow immune cells as they infiltrate the brain after such events and integrate into the resident microglial network. We track how this integration unfolds over weeks and months, and how it reshapes the brain's overall immune composition and response, providing insight into how repeated silent injury reshapes brain immunity over the long term.

Microglia and Vessels

Jasmin Hefendehl

Comorbidity of Alzheimer's pathology and vascular

In many older individuals, Alzheimer's pathology and vascular injury occur together rather than in isolation, and each can influence the course of the other. Amyloid deposits can weaken blood vessels and increase the risk of vascular injury, while vascular damage can in turn accelerate amyloid accumulation and impair the brain's ability to clear it. This bidirectional relationship makes comorbid cases both more common and more difficult to treat than either condition alone, yet most research still studies Alzheimer's disease and stroke as separate problems.

Our lab investigates this interaction directly, with particular attention to microglia, the brain's resident immune cells, and their capacity to respond to amyloid under combined vascular and neurodegenerative stress. We ask whether microglia exposed to both insults behave differently than those responding to either alone, and whether this dual exposure changes their ability to perform their normal protective functions. Candlish, Hofmann et al. (Journal of Neuroinflammation, 2026) demonstrated that microglia can adapt to this two-hit scenario and partially regain their capacity to clear amyloid, a finding that challenges the assumption that comorbidity simply compounds damage. Instead, it points toward new strategies for intervention in cases where multiple pathologies overlap, a scenario that reflects the reality of aging brains far more closely than single-pathology disease models.

Fachbereich Biowissenschaften

Prof. Dr. Jasmin K. Hefendehl

Profilbild von Prof. J. Hefendehl

Abteilungsleitung Neurovaskuläre Zellbiologie und Dysfunktion

  • Telefon+49 69 798 42528
  • Besuchsadresse
    Campus RiedbergBiologicumMax-von-Laue-Str. 1360438 Frankfurt am Main
    Raum1.221